Comparison of 5 methods of QT interval measurements on electrocardiograms from a thorough QT/QTc study: Effect on assay sensitivity and categorical outliers

Journal of Electrocardiology

Volumn 44, Issue 2, 2011, Pages 96-104

  Salvi, Vaibhav ^a   Karnad, Dilip R ^a   Panicker, Gopi Krishna ^a   Natekar, Mili ^a   Hingorani, Pooja ^a   Kerkar, Vaibhav ^a   Ramasamy, Arumugam ^a   De Vries, Michiel ^b   Zumbrunnen, Troy ^b   Kothari, Snehal ^a   Narula, Dhiraj ^a  

^a IQVIA   (United States)

^b Solvay Pharmaceuticals Inc   (Netherlands)

Author keywords

Arrhythmias; Cardiac repolarization; Electrocardiography; Long QT syndrome; QT prolongation; Sudden cardiac death; U wave

Indexed keywords

MOXIFLOXACIN; PLACEBO;

ARTICLE; CLINICAL ARTICLE; ELECTROCARDIOGRAM; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS;

ALGORITHMS; ANIMALS; ARTIFACTS; DIAGNOSIS, COMPUTER-ASSISTED; ELECTROCARDIOGRAPHY; HEART RATE; LONG QT SYNDROME; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 79952038265     PISSN: 00220736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jelectrocard.2010.11.010     Document Type: Article

References (30)

1. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use. The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs: E14. Geneva, Switzerland: International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use; 2005. Available at http://www.ich.org/LOB/media/MEDIA1476.pdf. Accessed 10 Oct 2008.
2. Xue J.Q. QT interval measurement: what can we really expect? Comput Cardiol 33 2006 385
3. Couderc J., and Zareba W. Assessment of ventricular repolarization from body-surface ECGs in humans J. Morganroth, I. Gussak, Cardiac safety of noncardiac drugs 2005 Humana Press Totowa, NJ 107
4. Lepeschkin E., and Surawicz B. The measurement of the QT interval of the electrocardiogram Circulation 6 1952 378
5. Panicker G.K., Karnad D.R., and Joshi R. Z score for benchmarking reader competence in a central ECG laboratory Ann Noninvasive Electrocardiol 42 2009 348
6. Garson A. How to measure the QT interval: what is normal? Am J Cardiol 72 1993 14B
7. Lund K., Perkiömäki J.S., and Brohet C. The prognostic accuracy of different QT interval measures Ann Noninvasive Electrocardiol 7 2002 10
8. A. Camm, M. Malik, Y. Yap, Acquired long QT syndrome 2004 Blackwell Futura Malden, MA 31
9. Mortara D.W. Automated QT measurement and application to detection of moxifloxacin-induced changes Ann Noninvasive Electrocardiol 14 2009 S30
10. Viskin S., Rosovski U., and Sands A.J. Inaccurate electrocardiographic interpretation of long QT: the majority of physicians cannot recognize a long QT when they see one Heart Rhythm 2 2005 569
11. Sarapa N., Nickens D.J., and Raber S.R. Ritonavir 100 mg does not cause QTc prolongation in healthy subjects: a possible role as CYP3A inhibitor in thorough QTc studies Clin Pharmacol Ther 83 2008 153
12. Iwamoto M., Kost J.T., and Mistry G.C. Raltegravir thorough QT/QTc study: a single supratherapeutic dose of raltegravir does not prolong the QTcF interval J Clin Pharmacol 48 2008 726
13. Zhang L., Chappell J., and Gonzales C.R. QT effects of duloxetine at supratherapeutic doses: a placebo and positive controlled study J Cardiovasc Pharmacol 49 2007 146
14. Davis J.D., Hackman F., Layton G., Higgins T., Sudworth D., and Weissgerber G. Effect of single doses of maraviroc on the QT/QTc interval in healthy subjects Br J Clin Pharmacol 65 Suppl 1 2008 68
15. Dixon R., Job S., and Oliver R. Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects Br J Clin Pharmacol 66 2008 396
16. Natekar M., Hingorani P., and Gupta P. Effect of number of replicate electrocardiographs recorded at each time point in a thorough QT study on sample size and study cost J Clin Pharmacol. 2010 [Electronic publication ahead of print]
17. Surawicz B., and Knilans T. Chou's electrocardiography in clinical practice 6th ed 2008 Saunders Elsevier Philadelphia, PA 17
18. Badilini F., and Sarapa N. Implications of methodological differences in digital electrocardiogram interval measurement J Electrocardiol 39 4 Suppl 2006 S152
19. Salvi V., Karnad D.R., Panicker G.K., and Kothari S. Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development Br J Pharmacol 159 2010 34
20. Committee for Proprietary Medicinal Products. Points to consider: the assessment of the potential for QT interval prolongation by noncardiovascular medicinal products, 1997. Available at: http://www.fda.gov/OHRMS/DOCKETS/ac/03/ briefing/pubs%5Ccpmp.pdf.
21. Ireland R.H., Robinson R.T.C.E., Heller S.R., and Harris N.D. QT measurement for TU fused ECG morphology as exhibited during hypoglycaemia Proceedings of the Twentieth Annual International Conference of the IEEE Engineering in Medicine and Biology Society 1998 240
22. Couderc J.P., McNitt S., and Hyrien O. Improving the detection of subtle I(Kr)-inhibition: assessing electrocardiographic abnormalities of repolarization induced by moxifloxacin Drug Saf 31 2008 249
23. Azie N.E., Adams G., and Darpo B. Comparing methods of measurement for detecting drug-induced changes in the QT interval: implications for thoroughly conducted ECG studies Ann Noninvasive Electrocardiol 9 2004 166
24. Tyl B., Kabbaj M., Fassi B., De Jode P., and Wheeler W. Comparison of semiautomated and fully automated methods for QT measurement during a thorough QT/QTc study: variability and sample size considerations J Clin Pharmacol 49 2009 905
25. Sarapa N., Francom S.F., Azzam S.M., Wickremasingha P.K., and Tyl B. Detection of clinically significant QTc prolongation in phase I studies in healthy participants: comparison of 2 semiautomated QT measurement methods J Clin Pharmacol 49 2009 103
26. Savelieva I., Yi G., Guo X., Hnatkova K., and Malik M. Agreement and reproducibility of automatic versus manual measurement of QT interval and QT dispersion Am J Cardiol 81 1998 471
27. Darpo B., Agin M., and Kazierad D.J. Man versus machine: is there an optimal method for QT measurements in thorough QT studies? J Clin Pharmacol 46 2006 598
28. Malik M., and Batchvarov V.N. Measurement, interpretation and clinical potential of QT dispersion J Am Coll Cardiol 36 2000 1749
29. Sadanaga T., Sadanaga F., Yao H., and Fujishima M. An evaluation of ECG leads used to assess QT prolongation Cardiology 105 2006 149
30. Couderc J.P. Measurement and regulation of cardiac ventricular repolarization: from the QT interval to repolarization morphology Philos Transact A Math Phys Eng Sci 367 2009 1283